Co-founder & CEO

Daniel completed his bachelor at the University of Oxford and PhD at Imperial College London. His PhD project focused on cultivating unculturable bacteria and screening them for antibiotics.


Daniel has an MSc in Finance from IE Business School Madrid and has worked two years in investment banking for Barclays Capital. Alongside his PhD, Daniel worked on evaluating the commercial potential of spinouts from University College London, as part of his work for Albion Ventures.